UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003990 |
|---|---|
| Receipt number | R000004805 |
| Scientific Title | A Phase I /II Study of Bi-weekly XELIRI with Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy. |
| Date of disclosure of the study information | 2010/08/25 |
| Last modified on | 2016/02/16 10:52:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/08/03 19:47:51 | ||
| 2 | Update | 2010/08/04 16:04:41 | Acronym Acronym |
|
| 3 | Update | 2014/05/26 12:35:31 | Recruitment status |
|
| 4 | Update | 2014/11/09 14:01:54 | Key exclusion criteria |
|
| 5 | Update | 2014/11/09 14:02:19 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 6 | Update | 2016/02/16 10:52:00 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
